Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-019842
Filing Date
2023-05-09
Accepted
2023-05-09 17:07:03
Documents
56
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20230331.htm   iXBRL 10-Q 2223570
2 EX-31.1 enta-ex31_1.htm EX-31 13723
3 EX-31.2 enta-ex31_2.htm EX-31 13714
4 EX-32.1 enta-ex32_1.htm EX-32 15728
5 GRAPHIC img216036407_0.jpg GRAPHIC 87600
  Complete submission text file 0000950170-23-019842.txt   7932233

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT enta-20230331_def.xml EX-101.DEF 145846
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT enta-20230331.xsd EX-101.SCH 35835
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT enta-20230331_pre.xml EX-101.PRE 270041
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT enta-20230331_lab.xml EX-101.LAB 350071
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT enta-20230331_cal.xml EX-101.CAL 43273
50 EXTRACTED XBRL INSTANCE DOCUMENT enta-20230331_htm.xml XML 1630994
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 23903242
SIC: 2834 Pharmaceutical Preparations